Literature DB >> 8639086

Interferon alfa induces leukocyte capillary trapping in rat retinal microcirculation.

H Nishiwaki1, Y Ogura, K Miyamoto, N Matsuda, Y Honda.   

Abstract

BACKGROUND: Interferon alfa has been suggested as a possible treatment for choroidal neovascularization. However, retinal complications following interferon therapy have been reported.
OBJECTIVE: To evaluate the effects of interferon alfa on leukocyte dynamics in the rat retinal microcirculation.
METHODS: Interferon alfa of different doses was intravenously administered in rats. Leukocyte dynamics were observed with acridine orange digital fluorography, which uses a nuclear fluorescent dye of acridine orange and scanning laser ophthalmoscopy. This technique allows visualization of leukocyte movements in the retinal microcirculation in vivo.
RESULTS: After interferon alfa was administered, leukocytes adhered to vascular walls and became trapped in the retinal microcirculation. Leukocyte trapping was dose-dependent.
CONCLUSIONS: Interferon alfa increased leukocyte adherence to vascular endothelium and subsequent leukocyte trapping in the retinal capillaries. Interferon alfa may activate leukocytes, and activated leukocytes may be involved in the pathogenesis of microinfarction associated with interferon-induced retinopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639086     DOI: 10.1001/archopht.1996.01100130718014

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Severe interferon associated retinopathy.

Authors:  K L Tu; J Bowyer; K Schofield; S Harding
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

Review 2.  Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Authors:  Roderick O'Day; Mark C Gillies; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

3.  Pegylated interferon alpha-associated optic neuropathy.

Authors:  Kathleen T Berg; Bruce Nelson; Andrew R Harrison; Linda K McLoon; Michael S Lee
Journal:  J Neuroophthalmol       Date:  2010-06       Impact factor: 3.042

4.  Ophthalmological side effects of interferon therapy of chronic hepatitis C.

Authors:  Eman Medhat; Gamal Esmat; Eman Hamza; Amr Abdel Aziz; Waleed Fouad Fathalah; Samar Kamal Darweesh; Zeinab Zakaria; Sameh Mostafa
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

5.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

6.  Morphology and topography of retinal pericytes in the living mouse retina using in vivo adaptive optics imaging and ex vivo characterization.

Authors:  Jesse Schallek; Ying Geng; HoanVu Nguyen; David R Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-19       Impact factor: 4.799

7.  A Drop in Hemoglobin as an Association with Pegylated Interferon Retinopathy: A Novel Pathophysiology.

Authors:  Meghan Berkenstock; Shaivi Patel; Jessica Ackert
Journal:  J Curr Ophthalmol       Date:  2020-04-30

8.  Interferon-alpha-associated presumed ocular sarcoidosis.

Authors:  Deshka Doycheva; Christoph Deuter; Nicole Stuebiger; Manfred Zierhut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

9.  Ocular Side Effects of Systemic Drugs Used in Dermatology.

Authors:  Bhanu Prakash; H Mohan Kumar; Saranya Palaniswami; Borra Harish Lakshman
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

10.  Prospective study of clinical characteristics of melanoma patients with retinopathy caused by a high-dose interferon α-2b.

Authors:  Shijie Lan; Zhihua Cui; Qiliang Yin; Zhigang Liu; Lingling Liang; Hua He; Hesong Liu; Zhen Guo; Yingying Yu; Di Wu
Journal:  Melanoma Res       Date:  2021-12-01       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.